Advertisement

NS3/4A Protease Inhibitors (PIs)

Protease inhibitors (PIs) block a protein that plays a critical role in HCV replication: They bind to the viral protease, which is responsible for processing viral proteins. Incivek and Victrelis were the first generation of HCV protease inhibitors, followed by Olysio. PIs are no longer used in the United States to treat hepatitis C.

*generic or biosimilar available

E experimental


Last Reviewed: March 5, 2019


Advertisement

Hot topics


Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.